A new treatment for type 1 diabetes, called a "reverse vaccine" because it suppresses the immune system rather than stimulates it, has undergone successful human testing for the first time. The vaccine, developed by Dr. Lawrence Steinman of Stanford University, promotes insulin production by blocking the immune response. It still faces several more years of testing before it can be approved for the public.

Full Story:
The Verge

Related Summaries